Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2450 of 3546 entries
View as:

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

Phase: N/A Priority: Normal
NCT ID: NCT00622830 Org: User:
Start: 01/31/08 End: 03/31/08 Due: 03/31/09

Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00090077 Org: User:
Start: 04/30/04 End: - Due: -

A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01808326 Org: User:
Start: 04/30/13 End: 11/30/14 Due: 11/30/15

Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02791763 Org: User:
Start: 06/06/16 End: 10/26/18 Due: 10/26/19

Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00060918 Org: User:
Start: 06/30/01 End: 04/30/04 Due: 04/30/05

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Phase: N/A Priority: Normal
NCT ID: NCT01520909 Org: User:
Start: 03/31/12 End: 01/31/14 Due: 01/31/15

Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)

Phase: N/A Priority: Normal
NCT ID: NCT01476085 Org: User:
Start: 07/31/11 End: 10/31/11 Due: 10/31/12

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT01878825 Org: User:
Start: 07/18/13 End: 08/09/13 Due: 08/09/14

Arnuity® Ellipta® Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03184480 Org: User:
Start: 08/19/17 End: 03/17/21 Due: 03/17/22

Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

Phase: N/A Priority: Normal
NCT ID: NCT01376167 Org: User:
Start: 04/24/14 End: 11/18/16 Due: 11/18/17

The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00379600 Org: User:
Start: 11/30/04 End: 12/31/06 Due: 12/31/07

A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children.

Phase: N/A Priority: Normal
NCT ID: NCT02201225 Org: User:
Start: 10/01/14 End: 03/13/15 Due: 03/13/16

Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02578953 Org: User:
Start: 09/09/15 End: 12/15/15 Due: 12/15/16

Proof of Concept (POC) in Patients With Ischaemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01808261 Org: User:
Start: 05/18/13 End: 07/28/14 Due: 07/28/15

Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A

Phase: N/A Priority: Normal
NCT ID: NCT00792909 Org: User:
Start: 12/02/08 End: 07/02/09 Due: 07/02/10

Acute Osteoarthritis Experimental Model Study.

Phase: N/A Priority: Normal
NCT ID: NCT01231490 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

Phase: N/A Priority: Normal
NCT ID: NCT00062790 Org: User:
Start: 10/31/03 End: 07/31/05 Due: 07/31/06

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT05568797 Org: User:
Start: 10/14/22 End: 07/17/23 Due: 07/17/24

Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00549679 Org: User:
Start: 10/04/07 End: 12/15/08 Due: 12/15/09

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00355641 Org: User:
Start: 10/31/05 End: 10/31/07 Due: 10/31/08

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00358488 Org: User:
Start: 04/30/06 End: 01/31/07 Due: 01/31/08

Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00937950 Org: User:
Start: 08/05/09 End: 01/20/14 Due: 01/20/15

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

Phase: N/A Priority: Normal
NCT ID: NCT00544271 Org: User:
Start: 05/31/03 End: 01/31/04 Due: 01/31/05

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT05477186 Org: User:
Start: 08/12/22 End: 08/18/23 Due: 08/18/24

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

Phase: N/A Priority: Normal
NCT ID: NCT00765076 Org: User:
Start: 10/16/08 End: 12/04/09 Due: 12/04/10